Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 4.18% is 124% above its 5-year average of -17.32%, near the high end of its 5-year range (-413.56%–13.67%).
12.19% below its 12-month average of 4.76%.
Reported quarterly gross margin; no daily interpolation. Q1 FY2027 (2026-06-30): 12.73%.
GROSS MARGIN
4.18%
GROSS MARGIN AVG TTM
4.76%
GROSS MARGIN AVG 3Y
-38.74%
GROSS MARGIN AVG 5Y
-17.32%
GROSS MARGIN AVG 10Y
0.84%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-12.19%
CURRENT VS 3Y AVG
+110.79%
CURRENT VS 5Y AVG
+124.14%
CURRENT VS 10Y AVG
+397.07%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.92%
median of 850 covered companies
CURRENT VS SECTOR MEDIAN
-89.79%
vs the sector median at left
Market Cap
$1.93M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.87M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.86M
Gross Margin
66.25%
TTM Avg
56.00%
3Y Avg
15.40%
5Y Avg
30.93%
Market Cap
$1.84M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.81M
Gross Margin
-27160.00%
TTM Avg
-15340.00%
3Y Avg
-31827.66%
5Y Avg
-23181.46%
Market Cap
$2.15M
Gross Margin
-628.02%
TTM Avg
-265.21%
3Y Avg
-2905.33%
5Y Avg
-2576.02%
Market Cap
$2.16M
Gross Margin
59.72%
TTM Avg
60.22%
3Y Avg
60.72%
5Y Avg
66.21%
Market Cap
$1.60M
Gross Margin
-1128.89%
TTM Avg
-518.50%
3Y Avg
-213.30%
5Y Avg
-126.70%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Beyond Air, Inc. (XAIR) | $1.93M | 4.18% | 4.76% | -38.74% | -17.32% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.93M | 0.00% | 0.00% | 0.00% | 0.00% |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.87M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tenon Medical, Inc. (TNON)vs › | $1.86M | 66.25% | 56.00% | 15.40% | 30.93% |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.84M | 0.00% | 0.00% | 0.00% | 0.00% |
| Alaunos Therapeutics, Inc. (TCRT)vs › | $1.81M | -27160.00% | -15340.00% | -31827.66% | -23181.46% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.15M | -628.02% | -265.21% | -2905.33% | -2576.02% |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.16M | 59.72% | 60.22% | 60.72% | 66.21% |
| Silo Pharma, Inc. (SILO)vs › | $1.60M | -1128.89% | -518.50% | -213.30% | -126.70% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.31M | 63.43% | 61.72% | 62.82% | 60.98% |
Gross Margin
4.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 12.73% |
| 2026-06-30 | 8.86% |
| 2026-03-31 | 4.93% |
| 2025-12-31 | 13.67% |
| 2025-09-30 | -16.39% |
| 2025-03-31 | -2.78% |
| 2024-12-31 | -20.06% |
| 2024-09-30 | -135.84% |
| 2024-06-30 | -48.76% |
| 2024-03-31 | -109.15% |
| 2023-12-31 | -91.30% |
| 2023-09-30 | -80.75% |
| 2023-06-30 | -413.56% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | 100.00% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | 100.00% |
| 2020-03-31 | 100.00% |
| 2019-12-31 | 100.00% |
| 2019-09-30 | 100.00% |
| 2019-06-30 | 100.00% |
| 2019-03-31 | 100.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
